152 related articles for article (PubMed ID: 30338740)
1. Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.
Iqbal K; Imran M; Ullah S; Jamal M; Waheed Y
Curr HIV Res; 2018; 16(4):297-301. PubMed ID: 30338740
[TBL] [Abstract][Full Text] [Related]
2. HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
Compaore TR; Diarra B; Assih M; Obiri-Yeboah D; Soubeiga ST; Ouattara AK; Tchelougou D; Bisseye C; Bakouan DR; Compaore IP; Dembele A; Djigma WF; Simpore J
BMC Infect Dis; 2016 Jul; 16():336. PubMed ID: 27449138
[TBL] [Abstract][Full Text] [Related]
3. Association of single nucleotide polymorphisms of APOBEC3G with susceptibility to HIV-1 infection and disease progression among men engaging in homosexual activity in northern China.
Li Q; Qiao Y; Zhang G; He N; Zhang X; Jia X; Sun H; Wang C; Xu L
Arch Virol; 2017 Jan; 162(1):259-268. PubMed ID: 27730383
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.
Compaore TR; Soubeiga ST; Ouattara AK; Obiri-Yeboah D; Tchelougou D; Maiga M; Assih M; Bisseye C; Bakouan D; Compaore IP; Dembele A; Martinson J; Simpore J
PLoS One; 2016; 11(1):e0146386. PubMed ID: 26741797
[TBL] [Abstract][Full Text] [Related]
5. CORRIGENDUM to: Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.
Iqbal K; Imran M; Ullah S; Jamal M; Waheed Y
Curr HIV Res; 2019; 17(2):146. PubMed ID: 31545162
[TBL] [Abstract][Full Text] [Related]
6. [The associations between polymorphisms of APOBEC3G and different outcomes of persistent HBV infection].
Tian D; Zeng Z; Tian GB; Cui JJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):481-6. PubMed ID: 18647522
[TBL] [Abstract][Full Text] [Related]
7. Coding region variant 186H/R in Exon 4 of APOBEC3G among individuals of Western India.
Singh H; Marathe S; Nain S; Nema V; Angadi M; Bapat S; Pawar J; Ghate M; Sahay S; Gangakhedkar RR
APMIS; 2016 May; 124(5):401-5. PubMed ID: 26853443
[TBL] [Abstract][Full Text] [Related]
8. CUL5 and APOBEC3G Polymorphisms are Partially Implicated in HIV-1 Infection and Antiretroviral Therapy in a Brazilian Population.
da Silva RC; Coelho AVC; de Moura RR; Arraes LC; Brandão LAC; Guimarães RL; Crovella S
Curr HIV Res; 2017; 15(4):245-257. PubMed ID: 28302043
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the contribution of APOBEC3G haplotypes, on influencing HIV infection in a Zimbabwean paediatric population.
Mhandire K; Duri K; Mhandire D; Musarurwa C; Stray-Pedersen B; Dandara C
S Afr Med J; 2016 May; 106(6 Suppl 1):S119-23. PubMed ID: 27245545
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of APOBEC3G variations in West Indian HIV patients.
Singh H; Gangakhedkar RR
Microb Pathog; 2018 Aug; 121():325-330. PubMed ID: 29864532
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in children.
Singh KK; Wang Y; Gray KP; Farhad M; Brummel S; Fenton T; Trout R; Spector SA
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):197-203. PubMed ID: 23138837
[TBL] [Abstract][Full Text] [Related]
12. Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa.
Matume ND; Tebit DM; Gray LR; Turner SD; Rekosh D; Bessong PO; Hammarskjöld ML
BMC Med Genet; 2019 Jan; 20(1):21. PubMed ID: 30660178
[TBL] [Abstract][Full Text] [Related]
13. [Association between APOBEC3G polymorphisms and susceptibility to chronic hepatitis B].
You Z; Zhou F; Wang X; Chen C; Zhou J; Zhao D; Hu G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):769-71. PubMed ID: 23689004
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.
Covino DA; Purificato C; Catapano L; Galluzzo CM; Gauzzi MC; Vella S; Lefebvre E; Seyedkazemi S; Andreotti M; Fantuzzi L
Front Immunol; 2018; 9():1839. PubMed ID: 30135687
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Kanari Y; Magri G; Trabattoni D; Naddeo V; Lopalco L; Clivio A; Cesana E; Fasano F; Bergamaschi C; Mazzotta F; Miyazawa M; Clerici M
J Infect Dis; 2007 Apr; 195(7):960-4. PubMed ID: 17330785
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the APOBEC3G gene of Chinese rhesus macaques affect resistance to ubiquitination and degradation mediated by HIV-2 Vif.
Jiang ZQ; Yao XR; Yu H; Lu YE; Liu BL; Liu FL; Jin YB; Zhuo M; Zheng YT; Ling F
Arch Virol; 2019 May; 164(5):1353-1360. PubMed ID: 30859472
[TBL] [Abstract][Full Text] [Related]
17. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
[TBL] [Abstract][Full Text] [Related]
18. Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among North Indian individuals.
Rathore A; Chatterjee A; Yamamoto N; Dhole TN
Genet Test; 2008 Sep; 12(3):453-6. PubMed ID: 18652534
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B; Cen S; Jiang JD
Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
[TBL] [Abstract][Full Text] [Related]
20. Intracellular detection of differential APOBEC3G, TRIM5alpha, and LEDGF/p75 protein expression in peripheral blood by flow cytometry.
Mous K; Jennes W; De Roo A; Pintelon I; Kestens L; Van Ostade X
J Immunol Methods; 2011 Sep; 372(1-2):52-64. PubMed ID: 21784078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]